Your Comments On...

FDA Plans to Examine Scope of Complaints About Lasik

In response to complaints of double vision, blurry vision and other complications following popular laser surgery to improve eyesight, the Food and Drug Administration is looking for ways to better educate patients about the possible risks and to assess the scope of the problems, an official said...
 - 

By Rob Stein

 
Comments
© 2008 The Washington Post Company